Literature DB >> 7491779

Picornavirus 2A proteinase-mediated stimulation of internal initiation of translation is dependent on enzymatic activity and the cleavage products of cellular proteins.

E Ziegler1, A M Borman, F G Deliat, H D Liebig, D Jugovic, K M Kean, T Skern, E Kuechler.   

Abstract

Poliovirus and human rhinovirus 2A proteinases are known to stimulate translation initiation on the cognate viral Internal Ribosome Entry Segments (IRESes). The molecular mechanism of this translational transactivation was investigated in vitro using dicistronic mRNAs containing picornaviral IRESes as the intercistronic spacer and purified human rhinovirus type 2 and coxsackievirus B4 2A proteinases. The stimulation achieved on the HRV2 IRES in the presence of the cognate 2A proteinase at 1 microgram/ml was twofold; the maximum stimulation at 100 micrograms/ml was fivefold. The IRESes and proteinases from rhino- and enteroviruses were interchangeable; however, stimulation of translation initiation on a cardiovirus IRES by these proteinases was minimal. Studies using an inhibitor or a mutant 2A proteinase demonstrated that translation stimulation requires 2A-mediated enzymatic conversion of some cellular component(s). The HRV2 2A proteinase also stimulated translation initiation on full-length viral RNA, suggesting that 2A proteinase-mediated stimulation of IRES-driven translation has a physiological role.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491779     DOI: 10.1016/s0042-6822(95)90001-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning.

Authors:  Déborah Prévôt; Didier Décimo; Cécile H Herbreteau; Florence Roux; Jérôme Garin; Jean-Luc Darlix; Théophile Ohlmann
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

2.  Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins.

Authors:  L O Roberts; R A Seamons; G J Belsham
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

3.  In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyprotein.

Authors:  Emiliano P Ricci; Cécile H Herbreteau; Didier Decimo; Andreas Schaupp; Siddhartha A K Datta; Alan Rein; Jean-Luc Darlix; Théophile Ohlmann
Journal:  RNA       Date:  2008-05-21       Impact factor: 4.942

4.  Protein 2A is not required for Theiler's virus replication.

Authors:  T Michiels; V Dejong; R Rodrigus; C Shaw-Jackson
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Cap-independent translation initiation in Xenopus oocytes.

Authors:  B D Keiper; R E Rhoads
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

6.  Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.

Authors:  Akiko Yanagiya; Qingmei Jia; Seii Ohka; Hitoshi Horie; Akio Nomoto
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis.

Authors:  J R Doedens; T H Giddings; K Kirkegaard
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  2A protease is not a prerequisite for poliovirus replication.

Authors:  Hiroko Igarashi; Yasuko Yoshino; Miwako Miyazawa; Hitoshi Horie; Seii Ohka; Akio Nomoto
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

9.  The 5'CL-PCBP RNP complex, 3' poly(A) tail and 2A(pro) are required for optimal translation of poliovirus RNA.

Authors:  Sushma A Ogram; Allyn Spear; Nidhi Sharma; James B Flanegan
Journal:  Virology       Date:  2009-11-27       Impact factor: 3.616

10.  Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro.

Authors:  M Joachims; P C Van Breugel; R E Lloyd
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.